This new biomimetic material, created using advanced 3D-printing technology, mimics coral's porous structure and chemical composition, allowing it to integrate seamlessly with human bone.

In preclinical studies, the material demonstrated the ability to fully repair bone defects within three to six months and stimulate new cortical bone formation in just four weeks.

Key benefits of this substitute include rapid healing within two to four weeks, complete degradation within six to twelve months, and cost-effectiveness due to its potential for easy large-scale production.

Bone defects from fractures, tumors, and non-healing injuries are significant contributors to global disability, with traditional graft methods facing challenges such as limited supply and ethical concerns.

Dr. Zhidao Xia, who leads the research, emphasizes that this invention bridges the gap between synthetic substitutes and donor bone, providing a safe and effective solution that reduces reliance on donor bone.

Unlike existing synthetic bone graft substitutes, which often fail to match the performance of natural bone, this new material effectively addresses issues like slow dissolution and inflammation.

This innovation is expected to enhance patient quality of life, lower healthcare costs, and create new opportunities within the biomedical industry.

The research has been patented and published in the journal Bioactive Materials, involving collaboration with multiple universities and institutions.

Researchers at Swansea University have developed an innovative bone graft substitute inspired by coral, which promotes faster healing and naturally dissolves in the body.

The Swansea University team is actively seeking partnerships with companies and healthcare organizations to advance this technology on a global scale.